Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2000 3
2001 5
2002 34
2003 33
2004 31
2005 51
2006 45
2007 37
2008 36
2009 45
2010 44
2011 41
2012 34
2013 40
2014 43
2015 51
2016 43
2017 50
2018 36
2019 39
2020 32
2021 43
2022 39
2023 51
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

837 results

Results by year

Filters applied: . Clear all
Page 1
A new era in the science and care of kidney diseases.
Zoccali C, Mallamaci F, Lightstone L, Jha V, Pollock C, Tuttle K, Kotanko P, Wiecek A, Anders HJ, Remuzzi G, Kalantar-Zadeh K, Levin A, Vanholder R. Zoccali C, et al. Among authors: remuzzi g. Nat Rev Nephrol. 2024 Apr 4. doi: 10.1038/s41581-024-00828-y. Online ahead of print. Nat Rev Nephrol. 2024. PMID: 38575770 Review.
Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review.
Barbieri M, Chiodini P, Di Gennaro P, Hafez G, Liabeuf S, Malyszko J, Mani LY, Mattace-Raso F, Pepin M, Perico N, Simeoni M, Zoccali C, Tortorella G, Capuano A, Remuzzi G, Capasso G, Paolisso G; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators. Barbieri M, et al. Among authors: remuzzi g. Pharmacol Res. 2024 May;203:107146. doi: 10.1016/j.phrs.2024.107146. Epub 2024 Mar 16. Pharmacol Res. 2024. PMID: 38493928 Free article. Review.
Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases.
Perico L, Casiraghi F, Sônego F, Todeschini M, Corna D, Cerullo D, Pezzotta A, Isnard-Petit P, Faravelli S, Forneris F, Thiam K, Benigni A, Remuzzi G. Perico L, et al. Among authors: remuzzi g. Front Immunol. 2024 Feb 26;15:1335998. doi: 10.3389/fimmu.2024.1335998. eCollection 2024. Front Immunol. 2024. PMID: 38469301 Free PMC article.
The Italian health-care crisis-only a matter of funding?
Garattini L, Nobili A, Remuzzi G. Garattini L, et al. Among authors: remuzzi g. Lancet. 2024 Feb 24;403(10428):727-728. doi: 10.1016/S0140-6736(23)02224-9. Lancet. 2024. PMID: 38401960 No abstract available.
C3d-Targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complement.
Liu F, Ryan ST, Fahnoe KC, Morgan JG, Cheung AE, Storek MJ, Best A, Chen HA, Locatelli M, Xu S, Schmidt E, Schmidt-Jiménez LF, Bieber K, Henderson JM, Lian CG, Verschoor A, Ludwig RJ, Benigni A, Remuzzi G, Salant DJ, Kalled SL, Thurman JM, Holers VM, Violette SM, Wawersik S. Liu F, et al. Among authors: remuzzi g. Mol Ther. 2024 Apr 3;32(4):1061-1079. doi: 10.1016/j.ymthe.2024.02.001. Epub 2024 Feb 20. Mol Ther. 2024. PMID: 38382529 Free article.
Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy.
Zanchi C, Locatelli M, Cerullo D, Aumiller V, Corna D, Rottoli D, Schubert S, Noris M, Tomasoni S, Remuzzi G, Zoja C, Benigni A. Zanchi C, et al. Among authors: remuzzi g. Mol Immunol. 2024 Apr;168:10-16. doi: 10.1016/j.molimm.2024.02.010. Epub 2024 Feb 17. Mol Immunol. 2024. PMID: 38368725 Free article.
Sirtuins in kidney health and disease.
Perico L, Remuzzi G, Benigni A. Perico L, et al. Among authors: remuzzi g. Nat Rev Nephrol. 2024 May;20(5):313-329. doi: 10.1038/s41581-024-00806-4. Epub 2024 Feb 6. Nat Rev Nephrol. 2024. PMID: 38321168 Review.
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
Ruggenenti P, Reinhard L, Ruggiero B, Perna A, Perico L, Peracchi T, Fidone D, Gennarini A, Benigni A, Cortinovis M, Hoxha E, Remuzzi G. Ruggenenti P, et al. Among authors: remuzzi g. Am J Kidney Dis. 2024 May;83(5):588-600.e1. doi: 10.1053/j.ajkd.2023.10.013. Epub 2023 Dec 25. Am J Kidney Dis. 2024. PMID: 38151224
837 results